Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCostain Group Regulatory News (COST)

Share Price Information for Costain Group (COST)

Share Price is delayed by 15 minutes
Get Live Data
210.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 2.00 (0.962%)
Market Cap: £559.00m
COST Live PriceLast checked at - London Stock Exchange

Intraday Costain Group Share Chart

£20m Share Buyback Programme

10 Mar 2026 07:01

RNS Number : 9454V
Costain Group PLC
10 March 2026
 

 

10 March 2026

On-market Share Buyback Programme of £20m

 

Costain Group PLC ("Costain" or the "Group") today announces the launch of an on-market share buyback programme (the "Buyback") for a maximum aggregate consideration of £20m.

This follows the intention set out in the announcement dated 26 January 2026, which provided an update on the Group's new pension scheme agreement, enhanced shareholder returns and FY 25 trading. The removal of the dividend parity arrangement, as announced in the update, removed a significant constraint that was on Costain in respect of returns to shareholders.

Having considered the new agreement, the Group's cash performance and ongoing capital requirements, the Board has concluded that an on-market share buyback programme for a maximum aggregate consideration of £20m (excluding stamp duty and expenses) is an appropriate and value-enhancing use of cash, while maintaining the Group's financial flexibility to continue to invest in its strategy to deliver sustainable growth and attractive returns.

Any ordinary shares purchased by the Company will be cancelled and, accordingly, the Buyback will reduce the Company's share capital.

Details of the Buyback

Costain has instructed Panmure Liberum Limited ("Panmure Liberum") and Investec Bank plc ("Investec") to execute the Buyback. Costain has entered into a non-discretionary and irrevocable instruction with Panmure Liberum and Investec, pursuant to which Panmure Liberum (in respect of the First Tranche) and Investec (in respect of the Second Tranche) will each purchase the Company's ordinary shares of 1 pence each ("Ordinary Shares") for up to a maximum consideration of £10m for each tranche, each acting severally as riskless principal. The First Tranche will commence immediately. The Second Tranche will commence following completion of the First Tranche and it is anticipated it will end no later than 31 December 2026, subject to market conditions.

The maximum number of Ordinary Shares that can be purchased in aggregate under the First Tranche and Second Tranche is 20,481,508, being the number of shares the Company is authorised to purchase pursuant to the authority granted by shareholders at the Company's 2025 annual general meeting (the "2025 AGM") and any subsequent authority.

Panmure Liberum and Investec will make their trading decisions in relation to the Ordinary Shares independently of, and uninfluenced by, the Company, within the terms and pre-set parameters of the Buyback.

Any purchase of Ordinary Shares under the Buyback will take place in open market transactions and may be made from time to time depending on market conditions, share price and trading volumes. The Buyback will be effected under the general authority to repurchase Ordinary Shares granted by the Company's shareholders at the 2025 AGM and in accordance with Chapter 12 of the UK Financial Conduct Authority's Listing Rules, and Regulation (EU) No 596/2014 and Commission Delegated Regulation (EU) No 2016/1052 (both as they form part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018), including where relevant pursuant to the UK Market Abuse Regulation.

Any purchase of Ordinary Shares pursuant to the Buyback will be announced by no later the end of the 7th daily market session following the calendar day on which such transaction occurred.

The Company will make further announcements in due course following the completion of any repurchases. There is no guarantee that the Buyback will be implemented in full or that any Ordinary Shares will be repurchased by the Company. The Buyback will not impact the Company's existing Ordinary Share dividend policy, which will continue unaffected through the regular awards of interim and final dividends. At the time of this announcement, the Company's share capital comprises 266,714,895 Ordinary Shares with voting rights.

Enquiries:

 

Investors and analysts matt.jones@costain.com

Matt Jones, Costain +44 (0) 7860 922341

 

Financial media - Headland costain@headlandconsultancy.com

Andy Rivett-Carnac +44 (0) 7968 997 365

Charlie Twigg +44 (0) 7946 494 568

 

Notes to editors

 

Costain improves people's lives by creating connected, sustainable infrastructure that enables people and the planet to thrive. Through the delivery of predictable, best-in-class solutions across the transport, water, energy and defence markets, we are creating a sustainable future and securing a more prosperous, resilient and decarbonised UK.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCKKLFBQXLLBBZ
Date   Source Headline
21st Nov 20227:00 amRNSExtension of Bank Debt and Bonding Facilities
1st Nov 20224:42 pmRNSDirector/PDMR Shareholding
30th Sep 20222:32 pmRNSA303 Delivery Assurance Partnership
27th Sep 20227:00 amRNSDirectorate Change
24th Aug 20227:00 amRNSStrong operational resilience and cash performance
20th Jul 20227:00 amRNSTrading in line with strong cash performance
1st Jul 20224:40 pmRNSSecond Price Monitoring Extn
1st Jul 20224:35 pmRNSPrice Monitoring Extension
1st Jul 20229:00 amRNSBlock listing Interim Review
16th Jun 20222:17 pmRNSTR-1: Notification of Major holdings
1st Jun 202211:10 amRNSTotal Voting Rights
5th May 20224:47 pmRNSResult of AGM
5th May 20227:00 amRNSTrading in line with market expectations
4th May 20228:55 amRNSLONG TERM INCENTIVE PLAN – LISTING APPLICATION
6th Apr 20225:24 pmRNSGrant of Share Plan Awards
30th Mar 202210:30 amRNSNotice of AGM and Annual Report and Accounts
28th Mar 20227:00 amRNSDirectorate Change
25th Mar 20224:35 pmRNSPrice Monitoring Extension
10th Mar 20224:36 pmRNSPrice Monitoring Extension
9th Mar 20227:00 amRNSDirectorate Change
9th Mar 20227:00 amRNSStrong performance in 2021
24th Feb 20227:00 amRNSPeterborough & Huntingdon contract resolution
12th Jan 20227:00 amRNSDirectorate Change
4th Jan 202210:00 amRNSBlock Listing Six Monthly Return
13th Dec 20217:00 amRNSUpdate on P&H contract and current trading
10th Nov 202110:49 amRNSDirector/PDMR Shareholding
2nd Nov 20211:33 pmRNSDirector/PDMR Shareholding
28th Sep 20217:00 amRNSAppointment of non-executive director
17th Sep 20214:36 pmRNSPrice Monitoring Extension
25th Aug 20217:00 amRNSInterim Results
15th Jul 20217:00 amRNSHalf Year Trading Update
1st Jul 202110:30 amRNSBlock Listing Six Monthly Return
6th May 20213:45 pmRNSResults of 2021 AGM
6th May 20217:00 amRNSAGM Statement
20th Apr 20212:00 pmRNSDealings in Costain Shares
8th Apr 20214:05 pmRNSLong Term Incentive Plan Awards
8th Apr 20219:00 amRNSExercise of Nil Cost Options
1st Apr 20219:34 amRNSNotice of AGM and Annual Report and Accounts
16th Mar 20217:00 amRNSResults For The Year Ended 31 December 2020
4th Mar 20211:40 pmRNSNotice of Results
24th Feb 20211:30 pmRNSHolding(s) in Company
17th Feb 20217:00 amRNSSettlement Agreement relating to the A465 contract
27th Jan 20217:00 amRNSBoard changes
22nd Jan 202110:15 amRNSNOTIFICATION OF MAJOR HOLDINGS
5th Jan 20217:00 amRNSYear End Trading Update
4th Jan 202110:05 amRNSBLOCK LISTING SIX MONTHLY RETURN
1st Dec 20209:42 amRNSLong Term Incentive Plan Award
20th Nov 20207:00 amRNSAppointment of Chief Financial Officer
3rd Nov 20204:14 pmRNSDirector/PDMR Shareholding
29th Oct 20207:10 amRNSBoard Notification - External Directorship

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.